About Index Trending news
Lists
Pricing
Protagonist Therapeutics

Protagonist Therapeutics

Protagonist Therapeutics

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.

Elsewhere

Alexa global traffic share

04 Jun 2013
$14,000,000
Venture capital (Series B)
19 Sep 2006
$9,000,000
Venture capital (Series A)
Starfish Ventures, Lilly Ventures, QIC BioVentures